会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • COMPOSITION FOR SUSTAINED RELEASE OF AN AGENT
    • 用于持续发行代理的组合物
    • WO1997007788A2
    • 1997-03-06
    • PCT/US1996013787
    • 1996-08-29
    • ALKERMES CONTROLLED THERAPEUTICS, INC.LEE, Hye-JungJOHNSON, OluFunmi, L.ZALE, Stephen, E.TRACY, Mark, A.
    • ALKERMES CONTROLLED THERAPEUTICS, INC.
    • A61K09/54
    • A61K9/5084A61K9/1647
    • Composition for the sustained release of a biologically active agent in vivo. The composition comprises microcarriers containing a first solid-phase biocompatible material and a biologically active agent, wherein said microcarriers sustain in vivo release of the biologically active agent. The composition also contains particles of a second biocompatible solid-phase material wherein the second solid-phase material further sustains the in vivo release of the biologically active agent. The invention also relates to a method for sustaining effective serum levels of a biologically active agent in a subject, including forming an injectable dose containing an effective amount of a biologically active agent, wherein the agent is contained in a microcarrier, with a release-period sustaining amount of a solid-phase material. The method further includes administering the injectable dose to the subject.
    • 用于体内持续释放生物活性剂的组合物。 该组合物包含含有第一固相生物相容性材料和生物活性剂的微载体,其中所述微载体维持生物活性剂的体内释放。 该组合物还含有第二生物相容性固相材料的颗粒,其中第二固相材料进一步维持生物活性剂的体内释放。 本发明还涉及一种用于维持受试者中生物活性剂有效血清水平的方法,包括形成含有有效量的生物活性剂的可注射剂量,其中所述试剂包含在微载体中,释放期 维持量的固相材料。 该方法还包括向受试者施用可注射剂量。